132 related articles for article (PubMed ID: 12686824)
1. Fracture risk following bilateral orchiectomy.
Melton LJ; Alothman KI; Khosla S; Achenbach SJ; Oberg AL; Zincke H
J Urol; 2003 May; 169(5):1747-50. PubMed ID: 12686824
[TBL] [Abstract][Full Text] [Related]
2. Osteoporosis after orchiectomy for prostate cancer.
Daniell HW
J Urol; 1997 Feb; 157(2):439-44. PubMed ID: 8996327
[TBL] [Abstract][Full Text] [Related]
3. Fracture risk in monoclonal gammopathy of undetermined significance.
Melton LJ; Rajkumar SV; Khosla S; Achenbach SJ; Oberg AL; Kyle RA
J Bone Miner Res; 2004 Jan; 19(1):25-30. PubMed ID: 14753733
[TBL] [Abstract][Full Text] [Related]
4. Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: a matched cohort study of 19,079 men.
Alibhai SM; Duong-Hua M; Cheung AM; Sutradhar R; Warde P; Fleshner NE; Paszat L
J Urol; 2010 Sep; 184(3):918-23. PubMed ID: 20643458
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors for low trauma fractures in men with prostate cancer.
Ahlborg HG; Nguyen ND; Center JR; Eisman JA; Nguyen TV
Bone; 2008 Sep; 43(3):556-60. PubMed ID: 18585119
[TBL] [Abstract][Full Text] [Related]
6. Incidence of fractures causing hospitalisation in prostate cancer patients: results from the population-based PCBaSe Sweden.
Thorstenson A; Bratt O; Akre O; Hellborg H; Holmberg L; Lambe M; Bill-Axelson A; Stattin P; Adolfsson J
Eur J Cancer; 2012 Jul; 48(11):1672-81. PubMed ID: 22386317
[TBL] [Abstract][Full Text] [Related]
7. Health care cost associated with prostate cancer, androgen deprivation therapy and bone complications.
Krupski TL; Foley KA; Baser O; Long S; Macarios D; Litwin MS
J Urol; 2007 Oct; 178(4 Pt 1):1423-8. PubMed ID: 17706711
[TBL] [Abstract][Full Text] [Related]
8. Fracture risk in Danish men with prostate cancer: a nationwide register study.
Abrahamsen B; Nielsen MF; Eskildsen P; Andersen JT; Walter S; Brixen K
BJU Int; 2007 Oct; 100(4):749-54. PubMed ID: 17822455
[TBL] [Abstract][Full Text] [Related]
9. Long-term fracture risk among women with proven endometriosis.
Melton LJ; Leibson CL; Good AE; Achenbach SJ; Oberg AL; Khosla S
Fertil Steril; 2006 Dec; 86(6):1576-83. PubMed ID: 17067584
[TBL] [Abstract][Full Text] [Related]
10. Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer.
Smith MR; Lee WC; Brandman J; Wang Q; Botteman M; Pashos CL
J Clin Oncol; 2005 Nov; 23(31):7897-903. PubMed ID: 16258089
[TBL] [Abstract][Full Text] [Related]
11. Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.
Higano CS
Urol Clin North Am; 2004 May; 31(2):331-52. PubMed ID: 15123412
[TBL] [Abstract][Full Text] [Related]
12. Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer.
Smith MR; Boyce SP; Moyneur E; Duh MS; Raut MK; Brandman J
J Urol; 2006 Jan; 175(1):136-9; discussion 139. PubMed ID: 16406890
[TBL] [Abstract][Full Text] [Related]
13. Primary hyperparathyroidism and the risk of fracture: a population-based study.
Khosla S; Melton LJ; Wermers RA; Crowson CS; O'Fallon Wm; Riggs Bl
J Bone Miner Res; 1999 Oct; 14(10):1700-7. PubMed ID: 10491217
[TBL] [Abstract][Full Text] [Related]
14. Fracture risk among patients with Paget's disease: a population-based cohort study.
Melton LJ; Tiegs RD; Atkinson EJ; O'Fallon WM
J Bone Miner Res; 2000 Nov; 15(11):2123-8. PubMed ID: 11092393
[TBL] [Abstract][Full Text] [Related]
15. Fracture risk with multiple myeloma: a population-based study.
Melton LJ; Kyle RA; Achenbach SJ; Oberg AL; Rajkumar SV
J Bone Miner Res; 2005 Mar; 20(3):487-93. PubMed ID: 15746994
[TBL] [Abstract][Full Text] [Related]
16. Long-term fracture risk among children with asthma: a population-based study.
Melton LJ; Patel A; Achenbach SJ; Oberg AL; Yunginger JW
J Bone Miner Res; 2005 Apr; 20(4):564-70. PubMed ID: 15765174
[TBL] [Abstract][Full Text] [Related]
17. Osteoporosis and fractures after androgen deprivation initiation for prostate cancer.
Malcolm JB; Derweesh IH; Kincade MC; DiBlasio CJ; Lamar KD; Wake RW; Patterson AL
Can J Urol; 2007 Jun; 14(3):3551-9. PubMed ID: 17594745
[TBL] [Abstract][Full Text] [Related]
18. 10-year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort: an analysis from the Manitoba Bone Density Program.
Hodsman AB; Leslie WD; Tsang JF; Gamble GD
Arch Intern Med; 2008 Nov; 168(20):2261-7. PubMed ID: 19001204
[TBL] [Abstract][Full Text] [Related]
19. Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy.
Krupski TL; Smith MR; Lee WC; Pashos CL; Brandman J; Wang Q; Botteman M; Litwin MS
Cancer; 2004 Aug; 101(3):541-9. PubMed ID: 15274067
[TBL] [Abstract][Full Text] [Related]
20. The impact of osteoporosis in men treated for prostate cancer.
Oefelein MG; Resnick MI
Urol Clin North Am; 2004 May; 31(2):313-9. PubMed ID: 15123410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
